EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 55.50
+0.30 (0.54%)
At close: Mar 6, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 1.64 billion as of March 6, 2026. Its market cap has decreased by -32.87% in one year.
Market Cap
1.64B
Enterprise Value
2.00B
Revenue
425.75M
Ranking
n/a
PE Ratio
56.65
Stock Price
55.50
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 1.64B, an increase of 1,995.17%. That is a compound annual growth rate of 28.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cereno Scientific AB | 1.89B |
| Orexo AB | 911.55M |
| Cinclus Pharma Holding AB | 812.55M |
| Nanexa AB | 658.34M |
| Dicot Pharma AB | 596.77M |
| Moberg Pharma AB | 481.76M |
| Enzymatica AB | 475.76M |
| BioGaia AB | 11.20B |